• ASX 200 rises 0.3%, Perpetual reveals large US acquisition

    ASX 200

    The S&P/ASX 200 Index (ASX: XJO) rose 0.3% today to 6,044 points despite initially being in the red this morning.

    In NSW, first home property buyers are getting boost as brand new homes priced under $800,000 temporarily won’t have to pay stamp duty. The NSW government hopes this will boost construction and support building industry jobs. Vacant land will also be eligible for the relief.

    Perpetual Limited (ASX: PPT) US acquisition

    Fund manager Perpetual announced that it’s going to acquire a 75% stake in US-based asset manager Barrow Hanley for $465 million.

    Barrow Hanley manages approximately US$44.1 billion of funds across US, global, and emerging market equities as well as fixed income strategies.

    Perpetual said it was an important acquisition to deliver sustained quality growth and it will diversify its investment capabilities.

    The ASX 200 fund manager business expects to add more than 20% of underlying earnings per share (EPS) on an annualised basis from the date of completion. The acquisition is expected to complete by the end of the first half of FY21, subject to the usual approvals.

    The acquisition will be funded by a combination of a capital raising, a new debt facility and existing cash.

    Perpetual is going to raise $225 million in a fully underwritten institutional placement and then it hopes to raise another $40 million in a share purchase plan (SPP). The debt facility is for $284 million. The raising price is $30.30 per share, a 9.8% discount to the last closing price.

    The acquisition is expected to more than triple Perpetual’s funds under management (FUM) from $28.4 billion to $92.3 billion.

    The ASX 200 business said it’s expecting a statutory net profit of $82 million for FY20 and an underlying profit after tax of $93.5 million.

    Emeco Holdings Limited (ASX: EHL) FY20 result

    Mining heavy equipment rental business Emeco announced its FY20 result today.

    Emeco’s revenue rose by 16.3% to $540.4 million. Iron ore revenue more than tripled and gold revenue more than doubled. Operating earnings before interest, tax, depreciation and amortisation (EBITDA) increased 15% to $246.1 million. Operating earnings before interest and tax (EBIT) rose by 10% to $138.2 million and operating net profit after tax (NPAT) went up 39% to $87.5 million.

    The statutory NPAT rose 94.7% to $66.1 million.  Emeco said it generated “strong” free cash flow of $71.2 million.

    Managing director of Emeco, Ian Testrow, spoke about the company’s aims for this year: “Our goals for FY21 are consistent to continue to diversify our commodity mix, expand the services the business provides, adding capital-light earnings, and continue to generate strong return on capital and cash flows to further deleverage. This will ensure we drive sustained shareholder returns.”

    St Barbara Ltd (ASX: SBM) acquisition

    The ASX 200 gold miner announced today it has agreed to acquire 100% of the shares in Moose River Resources Incorporated (MRRI). After this acquisition, St Barbara will own 100% of the Touquoy Mine and surrounding exploration tenements.

    The proposal is that St Barbara will acquire the remaining shares for cash of approximately C$60 million. It will be funded from St Barbara’s existing cash reserves. The deal will require approval of 75% of MRRI shareholders and it’s subject to normal approvals.

    St Barbara expects to complete the deal in early September 2020.

    Mr Craig Jetson, managing director and CEO of St Barbara, said: “Touquoy is a low-cost operation, generating impressive margins and is located in a very favourable and prospective jurisdiction. It produced a record 106,663 ounces of gold in FY20, reinforcing the credentials of this operation and the value it is delivering to St Barbara.

    “Assuming full control of the business will provide operational efficiencies , deliver financial benefits and allow us to truly realise the potential of the asset. In addition to developing our existing project pipeline we are exploring in the Moose River Corridor and elsewhere in Nova Scotia to identify further development opportunities.”

    Where to invest $1,000 right now

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    Scott just revealed what he believes are the five best ASX stocks for investors to buy right now. These stocks are trading at dirt-cheap prices and Scott thinks they are great buys right now.

    *Returns as of June 30th

    More reading

    Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

    The post ASX 200 rises 0.3%, Perpetual reveals large US acquisition appeared first on Motley Fool Australia.

    from Motley Fool Australia https://ift.tt/2OVpluS

  • Is it too late to buy the outperforming Woolworths share price and Coles share price?

    retail shares

    It’s hard to get away from the Coles Group Ltd (ASX: COL) share price and Woolworths Group Ltd (ASX: WOW) when it comes to defensive businesses that benefit from COVID-19.

    Grocery sales are booming due to the coronavirus lockdown but many may feel they’ve missed the boat.

    The Coles share price jumped over 20% since the start of the year while the Woolworths and Metcash Limited (ASX: MTS) share prices have gained around 8% each.

    In contrast, the S&P/ASX 200 Index (Index:^AXJO) lost 10% despite the big bounce from its March bear market low.

    More room to climb

    But I don’t think it’s too late to buy these stocks as we head into what is likely to be a nerve wrecking reporting season.

    Stocks with profit upside and a relatively low level of earnings risks are in demand and will continue to command a market premium.

    Supermarket stocks fit the bill and this isn’t the only reason to buy the sector.

    Profit margin boost

    The analysts at Macquarie Group Ltd (ASX: MQG) believe Woolies and Coles will enjoy fatter profit margins in the nearer-term, although this tailwind won’t last.

    “We believe COL and WOW should have a tailwind to margins on the back of improved volumes over at least FY20 and FY21,” said the broker.

    “However, we note that excess margins in supermarkets have consistently been lost to competition, inflation, regulation, staff costs or management follies.”

    Excess profits to flow online

    There’s another reason why the benefits from expanding margins won’t flow to shareholders. The broker noted that Woolies and Coles have underinvested in their online capabilities and will be using any extra profit they can get to play catch up.

    This isn’t a bad thing, in my opinion. Having a strong online business will provide the two supermarket giants with a competitive edge over rivals like Aldi.

    But despite the potential negatives, Macquarie has an “outperform” (meaning “buy”) recommendation on both stocks.

    This is in part due to expectations that investors will rotate out of the consumer discretionary sector and into retailers that sell staple goods.

    Better placed than other retailers

    “We are cautious on the current level of consumer discretionary spending and believe a second wave of the virus, coupled with a gradual reduction in fiscal stimulus will see some spending divert from consumer durables into services,” explained Macquarie.

    “This puts pressure on the discretionary space into FY21. We see more sustainability of earnings in the staples sector at the current point in the cycle.”

    Looking for other ASX stocks that can outperform during the reporting season? The experts at the Motley Fool have picked a number of bargain stocks to buy today.

    Follow the link below to find out for free what these stocks are.

    5 stocks under $5

    We hear it over and over from investors, “I wish I had bought Altium or Afterpay when they were first recommended by The Motley Fool. I’d be sitting on a gold mine!” And it’s true.

    And while Altium and Afterpay have had a good run, we think these 5 other stocks are screaming buys. And you can buy them now for less than $5 a share!

    *Extreme Opportunities returns as of June 5th 2020

    More reading

    Motley Fool contributor Brendon Lau owns shares of Woolworths Limited. Connect with me on Twitter @brenlau.

    The Motley Fool Australia owns shares of COLESGROUP DEF SET and Woolworths Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

    The post Is it too late to buy the outperforming Woolworths share price and Coles share price? appeared first on Motley Fool Australia.

    from Motley Fool Australia https://ift.tt/39ubZiA

  • Aroa Biosurgery surges 80% on ASX IPO. Is it still good value?

    Colourful explosion to symbolise share price growth

    Aroa Biosurgery Ltd (ASX: ARX) knocked the lights out on its ASX opening day debut on Friday.

    The New Zealand-based medical company entered the Australian market on the final day of trading last week. It sold 40 million new shares at an initial offering of 75 cents per share, raising $30 million. Early investors sold another $15 million worth of shares.

    New investors clearly saw that as a bargain. By 11.10 am (AEST) on Friday, the Aroa share price had more than doubled to $1.52. By the closing bell, Aroa shares had declined slightly, finishing the day at $1.35. Still a healthy 80% daily gain.

    As you’d expect, Aroa founder and CEO Brian Ward was elated by the results. He told AAP, “We knew after the roadshow that we had good institutional demand, we knew today would go well, but it’s been surprising how well it’s gone. … It’s been quite a party.”

    What does Aroa Biosurgery do?

    Aroa is a soft tissue regeneration company focused on improving wound healing. Its regeneration platform, Endoform, is developed from sheep forestomach.

    The company says that Endoform is 20% to 60% less expensive than similar biological products manufactured by its competitors. Its products have been used in more than 4 million procedures at 600 hospitals.

    What next for Aroa?

    Aroa doesn’t plan to sit on its laurels. The company intends to use its initial public offering (IPO) funds to expand into the massive United States (US) market. It already has 5 commercial products approved for sale in the US.

    Today, the Aroa share price closed trading at $1.47, up another 8.89% from Friday’s close.

    While it would have been nice to get your hands on some shares at 75 cents, we may well look back at the current price of $1.47 as a grand bargain in a year’s time.

    3 “Double Down” Stocks To Ride The Bull Market

    Motley Fool resident tech stock expert Dr. Anirban Mahanti has stumbled upon three under-the-radar stock picks he believes could be some of the greatest discoveries of his investing career.

    He’s so confident in their future prospects that he has issued “double down” buy alerts on each of these three stocks to members of his Motley Fool Extreme Opportunities stock picking service.

    *Extreme Opportunities returns as of June 5th 2020

    More reading

    Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

    The post Aroa Biosurgery surges 80% on ASX IPO. Is it still good value? appeared first on Motley Fool Australia.

    from Motley Fool Australia https://ift.tt/39D33ru

  • Heavy Is the Head That Wears the Semiconductor Crown

    from Yahoo Finance https://ift.tt/2P0SvJe

  • Is the Megaport share price a long term buy?

    Graphic representation of internet of things

    The Megaport Ltd (ASX: MP1) share price has been an incredible performer over the last 12 months.

    Although its shares have fallen almost 17% from their June high, they are still up approximately 70% since this time last year.

    This compares to an 11.5% decline by the S&P/ASX 200 Index (ASX: XJO) over the same period.

    Why is the Megaport share price up 70% in 12 months?

    Investors have been scrambling to buy the shares of the global leading provider of elastic interconnection services after the pandemic accelerated the shift to the cloud.

    Its global platform allows users to organise all their connections from one place and bring their network together into an easy-to-use platform.

    This means businesses can build hybrid, multi-cloud, cloud-to-cloud, and disaster recovery solutions with multiple connections to regional and global services. And instead of managing each resource separately, Megaport brings everything together into a seamless process.

    Among its 1,842 customers (up 24% year on year), you’ll find a diverse range of companies such as Adobe, BHP Group Ltd (ASX: BHP), FedEx, ING, Tesla, and Zoom.

    Management notes that another driver of this strong customer growth has been its growing ecosystem, which is adding value to users.

    The company’s CEO, Vincent English, explained: “Megaport’s strategy revolves around driving more value for our customers, partners, and shareholders. We have grown our ecosystem to over 360 service providers and now connect customers to 197 cloud onramps – the most of any neutral global interconnection fabric.”

    “We’ve made it easier than ever for our customers and partners to securely connect to the services that power their businesses. This has paid off with strong growth in our regional business units which is underpinned by increased customer usage and the growing adoption of multicloud.”

    What about revenues and profits?

    From the aforementioned customers, the company is currently generating Monthly Recurring Revenue (MRR) of $5.7 million. This MRR equates to approximately $68.5 million on an annual basis.

    And while Megaport is making a loss at the moment while it pursues growth, it recently revealed that it is aiming to achieve EBITDA breakeven by the end of FY 2021.

    Mr English commented: “Profitability remains a company-wide priority. We will focus on achieving EBITDA breakeven by the close of Fiscal Year 2021 by driving further customer growth across all regions.”

    Looking ahead, the CEO appears confident that its strong growth can continue.

    “With our SDN reaching over 700 enabled data centres across 23 countries, we are well positioned to capture the demand for elastic interconnection to support the ever-increasing surge of data powered by the digital economy,” he added.

    Should you invest?

    Although the Megaport share price is up 70% over the last 12 months, I would still be a buyer if you’re planning to make a long term investment.

    Along with Macquarie Telecom Group Ltd (ASX: MAQ) and NEXTDC Ltd (ASX: NXT), I believe Megaport is well-placed for long term growth thanks to the structural industry tailwinds which are accelerating the cloud computing boom.

    5 stocks under $5

    We hear it over and over from investors, “I wish I had bought Altium or Afterpay when they were first recommended by The Motley Fool. I’d be sitting on a gold mine!” And it’s true.

    And while Altium and Afterpay have had a good run, we think these 5 other stocks are screaming buys. And you can buy them now for less than $5 a share!

    *Extreme Opportunities returns as of June 5th 2020

    More reading

    James Mickleboro owns shares of NEXTDC Limited. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of and recommends MEGAPORT FPO. The Motley Fool Australia has recommended MEGAPORT FPO. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

    The post Is the Megaport share price a long term buy? appeared first on Motley Fool Australia.

    from Motley Fool Australia https://ift.tt/2X0XDkP

  • Moderna Gets Another $472M Federal Funding For Late-Stage Coronavirus Vaccine Development

    Moderna Gets Another $472M Federal Funding For Late-Stage Coronavirus Vaccine DevelopmentModerna Inc. (NASDAQ: MRNA) announced Sunday it is receiving another $472 million funding from President Donald Trump's administration to support late-stage clinical development of its coronavirus vaccine candidate, including an expanded phase 3 study.What Happened The Cambridge, Massachusetts-based company was originally allocated a $483 billion award, in support of its mRNA-1273 vaccine candidate, as part of its contract with the Biomedical Advanced Research and Development Authority (BARDA). Now that amount is being ratcheted up to $955 million as Moderna expects to conduct phase 3 trials with a significantly higher number of participants.The biotechnology firm revealed that its phase 3 study, to be conducted in collaboration with the Anthony Fauci-led National Institute of Allergy and Infectious Diseases, is expected to begin Monday. The trial would include 30,000 participants in the United States.Why It Matters Moderna claims it's on track to deliver nearly 500 million doses of the vaccine per year, and it could scale that number up to 1 billion doses next year due to its strategic collaboration with Lonza Group AG (OTC: LZAGY).The company said it is also collaborating with Catalent Inc (NYSE: CTLT) for fill-finish manufacturing of the vaccine at that company's Indiana facility. Last week, Moderna suffered a setback in its vaccine development as it lost a bid to invalidate a key patent related to the technology for delivery of mRNA vaccines held by Arbutus Biopharma Corp (NASDAQ: ABUS).The U.S. government is upping investments in the development, testing and production of the COVID-19 treatment. Earlier this month, it promised $1.6 billion in funding to Novavax, Inc (NASDAQ: NVAX) for its vaccine's late-stage trial, reported Politico. "We're very close to the vaccine — I think we're going to have some very good results," Trump reportedly said Tuesday.Price Action Moderna shares closed 2.8% lower at $73.21 on Friday and traded about 1.1% higher in the after-hours session.See more from Benzinga * Johnson & Johnson Says Late-Stage Coronavirus Vaccine Trials Moved Ahead To September * Trump Administration Expects Coronavirus Vaccine Production To Start By The End Of Summer(C) 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

    from Yahoo Finance https://ift.tt/303hmSS

  • How investors can make the most of all this uncertainty

    Share market uncertainty

    As if the global coronavirus pandemic isn’t creating enough uncertainty in the stock markets, United States President Donald Trump and Chinese President Xi Jinping are back at it.

    It seems ages ago — though my calendar assures me it’s less than 6 months — that investors’ biggest concerns revolved around the US–China trade dispute.

    On one week, Donald Trump and Xi Jinping would make nice, and stock market indexes around the world would rally.

    The next week, the two leaders would promptly backflip, indicating a range of sticking points remained to reach a trade deal. And global stock market indexes would fall.

    In renewed sparring, the US ordered China to shutter its consulate in Houston, Texas last week. China swiftly responded, directing the US to close its consulate in Chengdu.

    Investors didn’t like it.

    In the US, the S&P 500 Index (INDEXSP: INX) fell 0.6% on Friday. All the major European indexes lost ground too, with Germany’s DAX PERFORMANCE-INDEX (INDEXDB: DAX) dropping 2%.

    ASX bucks the losing trend

    The news also saw ASX futures trading 0.5% lower. But futures traders look to have gotten that one wrong.

    At the time of writing, Aussie investors appear to have shrugged off the gloom, with the All Ordinaries Index (ASX: XAO) up 0.2% in afternoon trading.

    That tells you most of this new turmoil is already priced into the markets, which tend to be forward-looking.

    That doesn’t mean the markets always get it right. But what the numbers are telling you is that there are plenty of great opportunities on the ASX right now.

    No one can predict with any accuracy how US–Chinese relations will progress. And no one can tell you when and how the world will conquer COVID-19. Though rest assured, we will beat this virus together!

    But that uncertainty doesn’t mean you should sell your stock holdings and remain paralysed on the sidelines.

    Far from it…

    Buy your favourite stocks

    Since bottoming out on 23 March, the All Ords is up an eye-popping 35%. Yes, that’s still down 15.1% from its 20 February all-time high. But a remarkable recovery nonetheless.

    According to corporate advisory firm Vesparum Capital, we largely have retail investors like you to thank for those gains. Vesparum says retail investors have timed their entry back into the stock markets well. At least so far…

    Now I’m not suggesting you try to time the highs and lows here. Leave that to those day traders with cast iron stomachs and hefty credit lines.

    Rather, to follow the lead of Collins St Value Fund principal Michael Goldberg, you should buy your favourite stocks. 

    “I think what differentiates us is that we manage a concentrated portfolio of our favourite ideas,” Goldberg is quoted as saying in the Australian Financial Review (AFR).

    Collins St Value Fund returned 13.5% in 2019–2020. During that same time, the S&P/ASX 200 Index (ASX: XJO) lost 7.7%. That’s an impressive 21.2% outperformance.

    But you have to be willing to get outside your comfort zone. As quoted in the AFR article, Goldberg says:

    Over the last 12 months it’s been exceptional and 70 per cent of the stocks we’ve owned over the last year went up, in a market that was down more than 7 per cent. We’re not getting it right every time, but we’re spending all the time we can to get that informational advantage and ensure we’re not taking risks we don’t understand. … Sometimes doing those things that are a little bit uncomfortable, because no one else likes to be uncomfortable, can generate massive opportunity. It’s there if you go and grab it, but it’s not always comfortable to go grab it.

    The fund focuses on a small number of stocks, holding an average of 10 to 15 stocks. 

    As far as your own stock portfolio goes, you may choose to hold a few more. But keeping in mind the importance of diversification to help reduce risks, you probably don’t want to own any less.

    Foolish takeaway

    Trump and Xi may rattle their sabres. And the coronavirus may linger for longer than we’d like. But every day brings new opportunities to potentially make money in the stock markets.

    Don’t let the uncertainty scare you away.

    Where to invest $1,000 right now

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    Scott just revealed what he believes are the five best ASX stocks for investors to buy right now. These stocks are trading at dirt-cheap prices and Scott thinks they are great buys right now.

    *Returns as of June 30th

    More reading

    Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

    The post How investors can make the most of all this uncertainty appeared first on Motley Fool Australia.

    from Motley Fool Australia https://ift.tt/3f4BBnA

  • Why I would buy and hold NEXTDC and these quality ASX growth shares

    shares higher

    One of the keys to successful long-term investing is being able to identify companies that can consistently grow their earnings long into the future.

    If you can do this then you could set yourself up for some market beating returns over the long run.

    With that in mind, here are three top ASX shares that I think have strong long term growth prospects:

    a2 Milk Company Ltd (ASX: A2M)

    One of my favourite ASX growth shares is a2 Milk Company. Although its shares are certainly not cheap, I would still be a buyer of them if you’re prepared to make a long term investment. This is because of the incredible demand for its infant formula products in China, its strong pricing power, and its ongoing expansion in the North American fresh milk market. Combined with potential earnings accretive acquisitions and new product launches, I believe the company is well-placed to achieve further strong growth in FY 2021 and beyond.

    NEXTDC Ltd (ASX: NXT)

    Another top growth share to consider buying with a long term view is NEXTDC. Once again, although the data centre operator’s shares look expensive, I believe they are worthy of the premium. I remain confident that NEXTDC is in a strong position to deliver a level of earnings growth over the next decade that justifies the lofty multiples its shares trade at. This is because as the cloud computing boom accelerates, demand for NEXTDC’s innovative data centre outsourcing solutions and connectivity services is likely to increase significantly.

    Xero Limited (ASX: XRO)

    A final growth share to consider buying is this cloud-based business and accounting software provider. Xero has been growing at an explosive rate over the last few years thanks to the rapid adoption of its software by small businesses across the globe. The good news is that I believe this strong form can continue for some time to come. Especially given how management estimates that less than 20% of its global English-speaking target market is using cloud-based accounting software at present. I expect this number to increase materially in the future given the overwhelming benefits of cloud-based software over traditional alternatives.

    5 stocks under $5

    We hear it over and over from investors, “I wish I had bought Altium or Afterpay when they were first recommended by The Motley Fool. I’d be sitting on a gold mine!” And it’s true.

    And while Altium and Afterpay have had a good run, we think these 5 other stocks are screaming buys. And you can buy them now for less than $5 a share!

    *Extreme Opportunities returns as of June 5th 2020

    More reading

    James Mickleboro owns shares of NEXTDC Limited. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of Xero. The Motley Fool Australia owns shares of A2 Milk. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

    The post Why I would buy and hold NEXTDC and these quality ASX growth shares appeared first on Motley Fool Australia.

    from Motley Fool Australia https://ift.tt/3hI59sX

  • What APRA’s latest release means for ASX bank shares like Westpac

    miniature building made from australian currency notes

    The Australian Prudential Regulation Authority (APRA) this week released its Banking COVID-19 frequently asked questions (FAQs). 

    Here are a few of the key takeaways from the release and what it could mean for ASX bank shares like Westpac Banking Corp (ASX: WBC).

    What APRA’s update means for ASX bank shares

    Importantly, the update tackled the issue of loan repayment deferrals. Authorised deposit-taking institutions (ADIs) offering payment deferrals to businesses and other borrowers do not need to treat this as a period of arrears.

    That’s good news for ASX bank shares ahead of the earnings season. It’ll be interesting to see how Commonwealth Bank of Australia (ASX: CBA) reports its loan book with the rest of the big four to follow in October / November.

    APRA also gave some guidance on residential mortgage lending. The Aussie regulator acknowledged the challenges associated with loan serviceability assessments for borrowers amid the coronavirus pandemic.

    That could mean results for the ASX bank shares don’t fully reflect underlying deterioration in debt serviceability. 

    The Aussie regulator provided some commentary on both market risk and credit risk. Thanks to the volatility in the March bear market, APRA expects to see an increased level of market risk capital held by the Aussie banks.

    In terms of credit risk, one of the FAQs discussed revaluation of residential properties. That’s a hot topic right now and one that would concern both ASX bank share investors and homeowners.

    Thankfully for both, ADIs will not be expected to revalue residential mortgage properties. That could mean the loan book is looking a touch healthier in these earnings results.

    Foolish takeaway

    There’s a lot to unpack from APRA’s Banking COVID-19 FAQs. No one really wants to read regulatory documents just for fun.

    However, there are some important implications for ASX bank shares ahead of upcoming earnings releases. 

    While the longer-term implications of the pandemic aren’t yet clear, this clarification is a good thing. It means both investors and the banks are clearer on what’s ahead for annual and half-year reporting.

    Legendary stock picker names 5 cheap stocks to buy right now

    Motley Fool resident tech stock expert Dr. Anirban Mahanti has stumbled upon five stocks he believes could be some of the greatest discoveries of his investing career.

    These little-known ASX stocks are growing like gangbusters, yet you can buy them today for less than $5 a share. Click here to learn more.

    See these 5 cheap stocks

    More reading

    Motley Fool contributor Ken Hall has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

    The post What APRA’s latest release means for ASX bank shares like Westpac appeared first on Motley Fool Australia.

    from Motley Fool Australia https://ift.tt/2D72VEj